Trademark: 79324555
Word
B
Status
Registered
Status Code
700
Status Date
Tuesday, November 1, 2022
Serial Number
79324555
Registration Number
6886644
Registration Date
Tuesday, November 1, 2022
Mark Type
3000
Filing Date
Monday, May 24, 2021
Published for Opposition
Tuesday, August 16, 2022

Trademark Owner History

Classifications
5 Cultures of microorganisms for medical or veterinary use; medical dressings; pharmaceutical preparations for human use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for human use for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations for human use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations for human use, namely, anti-infectives; antifungal pharmaceutical preparations for human use; Chinese traditional medicinal herbs for human use; pharmaceutical preparations for human use for antitussive-cold; pharmaceutical preparations for human use for the prevention and treatment of cancer; pharmaceutical preparations for human use for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for human use for the treatment of heart rhythm disorders; medicated throat sprays for human use; diuretic pharmaceutical preparations for human use; pharmaceutical preparations for human use for the treatment of musculo-skeletal disorders; pharmaceutical preparations for human use for the treatment of hyperlipidemia; antitussives for human use; otorhinolaryngological pharmaceutical preparations for human use; anaesthetics for human use; pharmaceutical preparations for human, namely, antidepressants; pharmaceutical preparations for human use for the treatment of eye diseases and conditions; headache treatment pharmaceutical preparations for human use; nasal spray preparations for human use; medicines for human use for the treatment of gastrointestinal diseases; medicinal preparations for the mouth and as sprays for human use; thyroid and para-thyroid hormone pharmaceutical preparations for human use; sulfonamide pharmaceutical preparations for human use; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension for human use; pharmaceutical preparations acting on the central nervous system for human use; pharmaceutical preparations for human use for the treatment of erectile dysfunction; pharmaceutical solutions used in dialysis for human use; pharmaceutical preparations for human use for the treatment of bone diseases; antipyretic analgesics for human use; antiallergic medicines for human use; anti-diabetic pharmaceutical preparations for human use; hypnotic sedatives for human use; cardiovascular pharmaceutical preparations for medical purposes for human use; hemostatics for medical purposes for human use; antihemorrhoidal pharmaceutical preparations for human use; anti-epileptic pharmaceutical preparations for human use; cerebral hemorrhage prophylactic pharmaceutical preparations for human use; pharmaceutical preparations for human use for the treatment of immune system related diseases and disorders; pharmaceutical preparations for human use for treating hypertension; athlete's foot pharmaceutical preparations for human use; pharmaceutical preparations for human use for treating asthma; pharmaceutical preparations for human use for the treatment of hormonal disorders; medicated mouth treatment pharmaceutical preparations for human use; motion sickness medicines for human use; diarrhea medication for human use; pesticides; medicines for veterinary purposes, namely, pain relief medication; veterinary vaccines; anti-infectives products for veterinary use; bacteriological medicinal preparations for veterinary purposes; medicines for veterinary purposes, namely, for treatment of intestinal bacteria; medicines for veterinary purposes for the treatment of animals' skin diseases; medicines for veterinary purposes for the treatment of wounds; albumin dietary supplements for medical purposes; depuratives for the body; oxygen for medical purposes; nitrous oxide for medical use; radioactive substances for medical purposes
The mark consists of the left-slanting capital letter "B" in blue and the parallelogram on the upper left corner of the "B" in green. The white background is not claimed as a feature of the mark.
The color(s) blue and green is/are claimed as a feature of the mark.

Trademark Events
Mar 21, 2023
Final Decision Transaction Processed By Ib
Feb 28, 2023
Final Disposition Notice Sent To Ib
Feb 27, 2023
Final Disposition Processed
Feb 1, 2023
Final Disposition Notice Created, To Be Sent To Ib
Nov 1, 2022
Notice Of Registration Confirmation Emailed
Nov 1, 2022
Registered-Principal Register
Oct 17, 2022
Assigned To Examiner
Aug 17, 2022
Notification Processed By Ib
Aug 16, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 16, 2022
Published For Opposition
Jul 27, 2022
Notification Of Possible Opposition Sent To Ib
Jul 27, 2022
Notification Of Notice Of Publication E-Mailed
Jul 27, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 11, 2022
Approved For Pub - Principal Register
Jul 8, 2022
Teas/Email Correspondence Entered
Jul 7, 2022
Correspondence Received In Law Office
Jul 7, 2022
Teas Response To Office Action Received
Apr 4, 2022
Refusal Processed By Ib
Mar 14, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Mar 14, 2022
Refusal Processed By Mpu
Feb 12, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Feb 11, 2022
Non-Final Action Written
Feb 4, 2022
Assigned To Examiner
Nov 12, 2021
Application Filing Receipt Mailed
Nov 8, 2021
New Application Office Supplied Data Entered
Nov 5, 2021
Limitation From Original Application Entered
Oct 29, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24